Who Qualifies for a GLP-1? BMI, Health History and Insurance

An online eligibility quiz usually answers a narrower question than its headline suggests. It may tell you whether a service will offer an assessment. It cannot, by itself, establish that a medicine is appropriate, that a clinician will prescribe it or that your insurer will pay.

Before entering payment details, separate those decisions. This guide focuses on adult weight-management treatment; other diagnoses and pediatric care have their own requirements.

What BMI qualifies for weight-management medication?

NIDDK describes common adult prescribing thresholds as BMI 30 or higher, or BMI 27 or higher with a weight-related health problem, such as high blood pressure or type 2 diabetes¹. BMI is calculated from height and weight. It is a screening measure, so bring accurate, current measurements rather than adjusting your answers to pass a website's questionnaire.

A qualifying number starts a discussion. Ask which health condition is relevant to the proposed treatment and whether records are needed. If your BMI is below the usual weight-management range, do not assume that paying cash removes the need for a medical assessment. Ask the clinician to explain the indication and alternatives.

The GLP-1 drug list distinguishes medicines that share a drug class but have different approved uses. A familiar ingredient name does not make every product interchangeable.

Three approvals that are easy to confuse

Service eligibility means the platform accepts your age, location and care needs. Clinical eligibility means the prescriber considers a particular treatment appropriate. Coverage approval means your plan agrees to pay under its rules. Passing one does not settle the others.

Ask whether the assessment fee is collected before the clinician reviews your history, what happens if treatment is declined, and which portion can be refunded. A promise of fast delivery says little about these decisions. Our provider-selection guide explains how to check the consultation and follow-up process.

Keep a copy of the terms shown when you enroll. If the service cannot treat someone in your state or cannot manage a condition you disclose, establish the next step before purchasing a longer plan.

The exact product and indication matter

The current Wegovy label includes weight management, cardiovascular risk reduction in a defined adult population, and an injection-only indication for certain adults with MASH. Zepbound has adult weight-management and obstructive-sleep-apnea indications²³. These are distinct clinical uses, not extra boxes to select simply to obtain approval.

Tell the clinician which diagnosis you are seeking treatment for. If heart disease, sleep apnea or liver disease is part of the discussion, ask which records support that diagnosis and who will coordinate care. Our Wegovy heart-health guide and Zepbound sleep-apnea guide explain the evidence behind those specific uses.

What should the prescriber ask about?

Prepare a medication list, previous weight-management treatments, relevant diagnoses and pregnancy plans. Include medicines from other online services, over-the-counter products and supplements. Describe previous side effects and why any earlier treatment ended.

Wegovy and Zepbound are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN2; their labels also address serious hypersensitivity. They are not recommended with severe gastroparesis²³. These examples do not constitute a complete personal safety checklist. Describe symptoms and diagnoses accurately and let the prescriber review the full product information.

If you use insulin or other glucose-lowering treatment, ask who will manage that combination. If pregnancy is planned, raise it before treatment rather than after ordering a supply. The pregnancy and fertility guide and laboratory-monitoring guide offer focused questions for those conversations.

Why insurance may say no after a clinician says yes

A medically appropriate prescription does not guarantee a covered benefit. Ask your insurer about the exact drug, diagnosis, prior authorization and any required documentation. Request the reason for a denial in writing so the prescriber can determine whether an appeal or missing record is relevant.

Do not infer coverage from a provider's statement that it accepts insurance. That may describe visits rather than medication. Our prior-authorization guide separates benefit exclusions, clinical criteria and paperwork. Confirm the expected medication and care charges before deciding whether an uninsured alternative is affordable.

Comparing online services after the medical discussion

Choose a service that can deliver the treatment and follow-up your clinician recommends. Our Ro review describes a brand-name medication service with a separate membership charge. The Sesame Care review describes a marketplace where the care plan and medicine are also billed separately. Neither review establishes that the service can manage every medical condition.

The Found versus Sesame comparison is useful when comparing care formats and published service terms. For brand medication budgeting, use the Wegovy and Ozempic cost board, then confirm the exact product and required fees. A low advertised price should follow a suitable care plan, rather than determine the medical decision.

Leave the assessment with a clear next step

Ask which treatment is being considered, why it fits your diagnosis, what information remains missing and when follow-up will occur. Confirm who answers questions between visits and how records reach your usual clinician.

If medication is not recommended, ask what the alternative plan involves. An assessment can still be useful when its outcome is a referral, additional evaluation or a different treatment. Its value is a clear, appropriate decision with an explanation you understand, rather than a guaranteed prescription.